Dashboard
Manage Tickers

FBIO


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

fortress-biotech-q2-eps-073-beats-123-estimate-sales-1490m-beat-1477m-estimate
Fortress Biotech Q2 EPS $(0.73) Beats $(1....
08/13/2024 20:57:20

Fortress Biotech (NASDAQ:FBIO) reported quarterly losses of $(0.73) per share which beat the analyst consensus estimate of $(1....

hc-wainwright--co-reiterates-buy-on-fortress-biotech-maintains-24-price-target
HC Wainwright & Co. Reiterates Buy on Fort...
07/19/2024 17:49:43

HC Wainwright & Co. analyst Joseph Pantginis reiterates Fortress Biotech (NASDAQ:FBIO) with a Buy and maintains $24 pric...

fortress-biotechs-urica-therapeutics-entered-into-an-apa-royalty-agreement-urica-sold-the-rights-to-its-urat1-inhibitor-product-candidate-in-development-for-the-treatment-of-gout-dotinurad-and-related-intellectual-property-licenses-and-agreements-to-crystalys-therapeutics-in-return-for-common-stock-equal-to-35-of-crystalys-outstanding-equity
Fortress Biotech's Urica Therapeutics Ente...
07/19/2024 12:07:57

- SEC Filing

Core News & Articles
GC Cell And Checkpoint Therapeutics To Exp...
07/15/2024 12:03:33

Collaboration explores the potential synergistic effects of Checkpoint's anti-PD-L1, cosibelimab, in combination with the a...

around-10m-bet-on-this-tech--telecom-stock-check-out-these-3-stocks-insiders-are-buying
Around $10M Bet On This Tech & Telecom Sto...
07/12/2024 12:42:36

insiders-buying-fortress-biotech-and-2-other-stocks
Insiders Buying Fortress Biotech And 2 Oth...
07/11/2024 11:29:22

greenbrier-fortress-biotech-and-3-stocks-to-watch-heading-into-monday
Greenbrier, Fortress Biotech And 3 Stocks ...
07/08/2024 07:10:02

fortress-biotech-announces-pause-in-payment-of-dividends-on-9375-series-a-cumulative-redeemable-perpetual-preferred-stock-pausing-of-these-dividends-will-defer-700k-in-cash-dividend-payments-each-month
Fortress Biotech Announces Pause In Paymen...
07/05/2024 20:06:24

Fortress Biotech, Inc. (NASDAQ:FBIO, FBIOP)))) ("Fortress"), an innovative biopharmaceutical company focused on acquiri...

cantor-fitzgerald-reiterates-overweight-on-fortress-biotech
Cantor Fitzgerald Reiterates Overweight on...
06/20/2024 17:35:21

Cantor Fitzgerald analyst Jennifer Kim reiterates Fortress Biotech (NASDAQ:FBIO) with a Overweight.

mustang-bio-announces-registered-direct-offering-and-concurrent-private-placement-issuance-and-sale-of-613m-shares-of-common-stock-at-041-per-share-in-registered-direct-offering-additional-613m-unregistered-warrants-in-private-placement-offering-expected-to-close-on-or-about-june-21-2024
Mustang Bio Announces Registered Direct Of...
06/20/2024 12:57:03

why-is-penny-stock-mustang-bio-trading-over-190-on-monday
Why Is Penny Stock Mustang Bio Trading Ove...
06/17/2024 13:21:52

Mustang Bio shares soar 190.9% on high trading volume as Phase 1/2 trial data for CAR T-cell therapy MB-106 shows positive resu...

roth-mkm-reiterates-buy-on-fortress-biotech-maintains-10-price-target
Roth MKM Reiterates Buy on Fortress Biotec...
05/16/2024 17:42:33

Roth MKM analyst Jason Wittes reiterates Fortress Biotech (NASDAQ:FBIO) with a Buy and maintains $10 price target.

fortress-biotech-q1-2024-gaap-eps-103-beats-173-estimate-sales-13030m-miss-14131m-estimate
Fortress Biotech Q1 2024 GAAP EPS $(1.03) ...
05/15/2024 20:53:01

Fortress Biotech (NASDAQ:FBIO) reported quarterly losses of $(1.03) per share which beat the analyst consensus estimate of $(1....

fortress-biotech-doses-first-paitent-in-multi-center-phase-2-study-of-triplex-for-control-of-cytomegalovirus-in-patients-undergoing-liver-transplantation
Fortress Biotech Doses First Paitent In Mu...
05/14/2024 12:45:03

Helocyte, a majority-owned subsidiary of Fortress Biotech, is developing Triplex for the prevention and treatment of cytomegalo...

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
04/17/2024 20:31:15

fortress-biotech-q4-eps-053-beats-197-estimate-sales-1995m-beat-1489m-estimate
Fortress Biotech Q4 EPS $(0.53) Beats $(1....
03/29/2024 03:33:42

Fortress Biotech (NASDAQ:FBIO) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(1....

alliance-global-partners-initiates-coverage-on-fortress-biotech-with-buy-rating-announces-price-target-of-5
Alliance Global Partners Initiates Coverag...
03/19/2024 12:20:23

Alliance Global Partners initiates coverage on Fortress Biotech (NASDAQ:FBIO) with a Buy rating and announces Price Target of...

roth-mkm-reinstates-buy-on-fortress-biotech-announces-10-price-target
Roth MKM Reinstates Buy on Fortress Biotec...
03/15/2024 12:52:42

Roth MKM analyst Jason Wittes reinstates Fortress Biotech (NASDAQ:FBIO) with a Buy and announces $10 price target.

Core News & Articles
Phase 1 CAR T Cell Therapy Trial For Gliob...
03/07/2024 10:06:54

Half of the enrolled patients had stable disease for at least two months, two showed partial response and two experienced com...

fortress-biotech-and-cyprium-therapeutics-announce-41m-grant-from-ninds-to-further-thendevelopment-of-aav-atp7a-gene-therapy-for-menkes-disease
Fortress Biotech And Cyprium Therapeutics ...
03/04/2024 13:35:08

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION